Phyllis K. Bellin
Financieel Directeur/CFO bij Galimedix Therapeutics, Inc. (Maryland)
Profiel
Phyllis K.
Bellin is currently the Chief Financial Officer & Director at Galimedix Therapeutics, Inc. She previously worked as a Corporate Lending Officer at the University of Medicine & Dentistry of New Jersey and as Secretary, Treasurer & VP-Administration at Aevi Genomic Medicine, Inc. She holds an MBA degree from The Trustees of Columbia University in The City of New York.
Actieve functies van Phyllis K. Bellin
| Bedrijven | Functie | Begin |
|---|---|---|
Galimedix Therapeutics, Inc. (Maryland)
 Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | Financieel Directeur/CFO | - |
Eerdere bekende functies van Phyllis K. Bellin
| Bedrijven | Functie | Einde |
|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | - |
| AEVI GENOMIC MEDICINE, INC. | Financieel Directeur/CFO | 16-09-2013 |
Opleiding van Phyllis K. Bellin
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
Galimedix Therapeutics, Inc. (Maryland)
Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | Health Services |
